The trivalent-tandem CAR could target and recognize three different TAAs on the surface of glioblastoma cells, including human epidermal growth factor receptor 2 (HER2), interleukin-13 receptor subunit alpha-2 (IL13Rα2), and ephrin-A2 (EphA2). This evidence concerns the gene ERBB2 and glioblastoma.